z-logo
Premium
Results of laparotomy in immunoproliferative small intestinal disease
Author(s) -
Tabbane Francoise,
Mourali Nejib,
Cammoun Mohamed,
Najjar Taoofik
Publication year - 1988
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19880415)61:8<1699::aid-cncr2820610831>3.0.co;2-e
Subject(s) - medicine , exploratory laparotomy , laparotomy , small intestine , mesenteric lymph nodes , lymphoma , gastroenterology , disease , pathology , lymph , surgery , spleen
Immunoproliferative small intestinal diseases (IPSID), previously known as Mediterranean Lymphomas, constitute more than 60% of the non‐Burkitt's small intestinal lymphomas in Tunisia. A multidisciplinary study of IPSID was undertaken by the Tunisian/French Lymphoma Study Group in 1980 to reach a better understanding of the two subgroups of the disease: secreting IPSID (essentially alpha‐chain disease [ACD]); and nonsecreting IPSID (NS‐IPSID) (extensive small intestinal lymphomas without gammopathy). The results of initial exploratory laparotomy performed in 38 cases of IPSID (17 ACD and 21 NS‐IPSID) are described here, and show notable similarities between the two groups: the extensive pattern of the abnormal cell infiltrate along the major part of the small intestine; frequent and extensive involvement of the mesenteric lymph nodes; the existence of several degrees of severity in small intestinal mesenteric lymph nodes; and other intraabdominal organ involvement. Certain differences also were observed: the relatively high degree of tropism of the NS‐IPSID towards the gastric mucosa which was absent in the ACD of this series; and the more frequent involvement of the entire length of the small bowel in ACD. In spite of these discrete differences, the IPSID form a homogeneous group which is definitely distinguishable from the segmentary small intestinal lymphomas known as Western‐type, and which account for approximately one third of our non‐Burkitt's small bowel lymphomas.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here